Macular Disease Foundation Australia's purpose is to reduce the incidence and impact of macular disease, the leading cause of blindness and severe vision loss in Australia.

July 2022

Macular Disease Foundation Australia (MDFA) announces
Dr. Kathy Chapman as the new CEO

Macular Disease Foundation Australia (MDFA) is delighted to announce Dr. Kathy Chapman has been appointed the new Chief Executive Officer of the organisation. An experienced senior leader and CEO, Kathy commenced in the role on 18 July 2022.

Kathy brings to MDFA extraordinary experience as a dynamic and respected senior leader and CEO in the for-purpose sector, including public health and promoting inclusion for people with disabilities. Kathy’s executive career traverses key organisations such the Heart Foundation of Australia, Down Syndrome NSW, Cancer Council NSW, and the NSW Council of Social Services.

Kathy is an influential and decisive leader with significant experience setting and delivering on strategy, as well as scaling public health and advocacy programs to support the community. Everything MDFA does is underpinned by a commitment to people living with or at risk of macular disease; Kathy’s career of successful advocacy and leadership of preventative health programs makes her a perfect fit for the role.

MDFA Chair, Mr Graeme Head, AO, stated “the Board is delighted to have attracted someone as talented as Kathy—to continue our strong tradition of prevention and early detection, patient support, advocacy, and research, and build upon the outstanding work that is delivered by our staff and volunteers every day. We are confident that in Kathy we have found someone who will lead the organisation with innovation, distinction, and integrity.”

Click here to learn more about Dr Kathy Chapman.